Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis

References

• TakizawaDKakizakiSSoharaNHepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysisDig Dis Sci200752113290329517394062
   PubMed Web of Science ®Google Scholar
• LlovetJMBustamanteJCastellsANatural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trialsHepatology199929162679862851
   PubMed Web of Science ®Google Scholar
• BruixJShermanMAmerican Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an updateHepatology20115331020102221374666
   PubMed Web of Science ®Google Scholar
• VillanuevaAHernandez-GeaVLlovetJMMedical therapies for hepatocellular carcinoma: a critical view of the evidenceNat Rev Gastroenterol Hepatol2013101344223147664
   PubMed Web of Science ®Google Scholar
• LlovetJMFusterJBruixJBarcelona-Clínic Liver Cancer GroupThe Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinomaLiver Transpl2004102 Suppl 1S115S12014762851
   PubMedGoogle Scholar
• LlovetJMRicciSMazzaferroVSorafenib in advanced hepatocellular carcinomaN Engl J Med2008359437839018650514
   PubMed Web of Science ®Google Scholar
• FuQHZhangQBaiXLSorafenib enhances effects of transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysisJ Cancer Res Clin Oncol201414081429144024770582
   PubMed Web of Science ®Google Scholar
• BruixJRaoulJLShermanMEfficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trialJ Hepatol201257482182922727733
   PubMed Web of Science ®Google Scholar
• WelkerMWTrojanJAntiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safetyCancer Manag Res2013533734724204170
   PubMedGoogle Scholar
• JeongSWJangJYShimKYPractical effect of sorafenib mono-therapy on advanced hepatocellular carcinoma and portal vein tumor thrombosisGut Liver20137669670324312711
   PubMed Web of Science ®Google Scholar
• YauTChanPNgKKPhase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor responseCancer2009115242843619107763
   PubMed Web of Science ®Google Scholar
• NojiriSKusakabeAFujiwaraKClinical factors related to long-term administration of sorafenib in patients with hepatocellular carcinomaCancer Manag Res2012442342923293537
   PubMedGoogle Scholar
• KimKMKimJHParkISReappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasionJ Gastroenterol Hepatol200924580681419207681
   PubMed Web of Science ®Google Scholar
• GeorgiadesCSHongKD’AngeloMGeschwindJFSafety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosisJ Vasc Interv Radiol200516121653165916371532
   PubMed Web of Science ®Google Scholar
• LeeHSKimJSChoiIJChungJWParkJHKimCYThe safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled studyCancer19977911208720949179054
   PubMed Web of Science ®Google Scholar
• LuoJGuoRPLaiECTransarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative studyAnn Surg Oncol201118241342020839057
   PubMed Web of Science ®Google Scholar
• OkusakaTOkadaSIshiiHPrognosis of hepatocellular carcinoma patients with extrahepatic metastasesHepatogastroenterology199744132512579058154
   PubMed Web of Science ®Google Scholar
• JunCHYoonJHChoEBarcelona clinic liver cancer-stage C hepatocellular carcinoma: a novel approach to subclassification and treatmentMedicine20179617e674528445298
   PubMed Web of Science ®Google Scholar
• KatagiriSYamamotoMMultidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombusSurg Today201444221922623591833
   PubMed Web of Science ®Google Scholar
• HuangW-KYangS-FYouL-NTranscatheter arterial chemoembolisation (TACE) plus S-1 for the treatment of BCLC stage B hepatocellular carcinoma refractory to TACEWspółczesna Onkologia201666468474
   Google Scholar
• LencioniRLlovetJMModified RECIST (mRECIST) assessment for hepatocellular carcinomaSemin Liver Dis2010301526020175033
   PubMed Web of Science ®Google Scholar
• ShimJHLeeHCKimSOWhich response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new modelsRadiology2012262270871822187634
   PubMed Web of Science ®Google Scholar
• UrakiJYamakadoKNakatsukaATakedaKTranscatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factorsEur J Radiol2004511121815186879
   PubMed Web of Science ®Google Scholar
• NakaoNUchidaHKaminoKDetermination of the optimum dose level of lipiodol in transcatheter arterial embolization of primary hepatocellular carcinoma based on retrospective multivariate analysisCardiovasc Intervent Radiol199417276808013027
   PubMed Web of Science ®Google Scholar
• ChungGELeeJHKimHYTransarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survivalRadiology2011258262763421273524
   PubMed Web of Science ®Google Scholar
• SongDSSongMJBaeSHA comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosisJ Gastroenterol201550444545425027973
   PubMed Web of Science ®Google Scholar
• NiuZJMaYLKangPTransarterial chemoembolization compared with conservative treatment for advanced hepatocellular carcinoma with portal vein tumor thrombus: using a new classificationMed Oncol20122942992299722200992
   PubMed Web of Science ®Google Scholar